(Q40829474)

24 September 2017

title

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection (English)

1 reference

24 September 2017

0 references

vaccinia virus

1 reference

Nishikawa Y

1

1 reference

24 September 2017

Inoue N

2

1 reference

24 September 2017

Xuan X

3

1 reference

24 September 2017

Nagasawa H

4

1 reference

24 September 2017

Igarashi I

5

1 reference

24 September 2017

Fujisaki K

6

1 reference

24 September 2017

Otsuka H

7

1 reference

24 September 2017

Mikami T

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 September 2017

number of pages

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

11-12

1 reference

24 September 2017

page(s)

1381-1390

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

24 September 2017

1 reference

7 January 2021

Ultrastructure of tachyzoites, bradyzoites and tissue cysts of Neospora caninum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Experimental reproduction of bovine fetal Neospora infection and death with a bovine Neospora isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Neospora caninum: role for immune cytokines in host immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Development of heat-stable recombinant rinderpest vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Delivery of the Theileria parva p67 antigen to cattle using recombinant vaccinia virus: IL-2 enhances protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Identification and partial characterization of a 36 kDa surface protein on Neospora caninum tachyzoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Characterization of a cDNA-clone encoding Nc-p43, a major Neospora caninum tachyzoite surface protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Identification of a major surface protein on Neospora caninum tachyzoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

The major 36 kDa Neospora caninum tachyzoite surface protein is closely related to the major Toxoplasma gondii surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Comparison of the major antigens of Neospora caninum and Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Neospora caninum: specific oligonucleotide primers for the detection of brain "cyst" DNA of experimentally infected nude mice by the polymerase chain reaction (PCR).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900389-3

7 January 2021

10.1016/S0264-410X(00)00389-3

Identifiers

DOI

1 reference

24 September 2017

1 reference